Sofosbuvir induces gene expression for promoting cell proliferation and migration of hepatocellular carcinoma cells

Direct-acting antivirals (DAAs) have achieved a sustained virological response (SVR) rate of 95–99% in treating HCV. Several studies suggested that treatment with sofosbuvir (SOF), one type of DAAs, may be associated with increased risk of developing HCC. The aim of this study is to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Wei-Lun, Cheng, Jin-Shiung, Liu, Pei-Feng, Chang, Tsung-Hsien, Sun, Wei-Chih, Chen, Wen-Chi, Shu, Chih-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365546/
https://www.ncbi.nlm.nih.gov/pubmed/35833210
http://dx.doi.org/10.18632/aging.204170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365546/
https://www.ncbi.nlm.nih.gov/pubmed/35833210
http://dx.doi.org/10.18632/aging.204170

Ejemplares similares